Fisher Funds Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$43M Buy
37,181
+22,730
+157% +$26.8M 1.25% 17
2026
Q2
$17.3M Buy
14,451
+4,000
+38% +$4.09M 0.49% 61
2026
Q1
$9.6M Hold
10,451
– – 0.28% 84
2025
Q4
$11.3M Hold
10,451
– – 0.29% 80
2025
Q3
$7.97M Hold
10,451
– – 0.21% 98
2025
Q2
$8.15M Sell
10,451
-1,161
-10% -$902K 0.19% 91
2025
Q1
$9.6M Hold
11,612
– – 0.23% 85
2024
Q4
$8.94M Hold
11,612
– – 0.22% 81

Other funds holding LLY

Fisher Funds Management's LLY Position: Q3 2026 in Review

Fisher Funds Management increased its Eli Lilly (LLY) stake by 157% in Q3 2026, buying an estimated $26.8M and bringing the position to 37,181 shares worth $43M. The position accounts for 1.25% of the portfolio, ranked #17.

Fisher Funds Management first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Fisher Funds Management held 37,181 shares of Eli Lilly worth $43M as of Q3 2026.
  • Fisher Funds Management bought 22,730 Eli Lilly shares in Q3 2026, an estimated $26.8M.
  • Eli Lilly made up 1.25% of Fisher Funds Management's portfolio in Q3 2026, its #17 holding.
  • Fisher Funds Management first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Fisher Funds Management's 13F filing for Q3 2026, filed 13 Oct 2026.